Matches in Wikidata for { <http://www.wikidata.org/entity/Q92919075> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q92919075 description "article scientifique publié en 2020" @default.
- Q92919075 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92919075 description "scientific article published on 21 January 2020" @default.
- Q92919075 description "wetenschappelijk artikel" @default.
- Q92919075 description "наукова стаття, опублікована 21 січня 2020" @default.
- Q92919075 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 21-ին" @default.
- Q92919075 name "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 name "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 type Item @default.
- Q92919075 label "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 label "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 prefLabel "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 prefLabel "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 P1433 Q92919075-78264FE3-E29C-47E2-8A9D-4C57AA8C5260 @default.
- Q92919075 P1476 Q92919075-DA4A5CD9-82E5-419A-8DF1-CD858FCF6936 @default.
- Q92919075 P2093 Q92919075-0CA9D0F9-C120-4D97-ACE0-4606A1FDFBAF @default.
- Q92919075 P2093 Q92919075-282D741D-74C8-4ACF-B414-92F32EC10581 @default.
- Q92919075 P2093 Q92919075-43FDF231-43E6-4493-9F63-27577BAFDBEC @default.
- Q92919075 P2093 Q92919075-63AF3D00-DE56-4DFF-9AB0-AE51944AFE53 @default.
- Q92919075 P2093 Q92919075-6D275B0F-215D-4F9A-A1B1-14A90113C16E @default.
- Q92919075 P2093 Q92919075-84861339-1EF0-430B-BD02-07CD8655EF38 @default.
- Q92919075 P2093 Q92919075-8CB765BA-4968-4C1E-8131-713C5B110169 @default.
- Q92919075 P2093 Q92919075-C744FABC-1990-4488-85BC-993E78F8927C @default.
- Q92919075 P2093 Q92919075-D770BBED-814C-4CEF-828A-27F633485697 @default.
- Q92919075 P2093 Q92919075-DBB087C0-8AB6-44F5-8D61-520FFBD3D1EF @default.
- Q92919075 P2093 Q92919075-F1645780-06C7-4368-B651-E17C2DC89A60 @default.
- Q92919075 P304 Q92919075-C7B91EBE-06AA-4A21-82AC-CE67425BAEE8 @default.
- Q92919075 P31 Q92919075-1097645C-CCA6-4309-BCA7-3232755C1E3D @default.
- Q92919075 P356 Q92919075-F504DF47-6D53-4F34-BC77-E56A089EB703 @default.
- Q92919075 P478 Q92919075-F7559D83-F172-49B3-A07C-15FD96AA1F87 @default.
- Q92919075 P577 Q92919075-DCF2511F-D3E2-4ADD-A91F-19BE66926765 @default.
- Q92919075 P698 Q92919075-AEB98B27-25A9-4C26-88E0-4164E2D103F7 @default.
- Q92919075 P921 Q92919075-69946F8D-83D4-4833-92D2-D318F6F2C693 @default.
- Q92919075 P356 J.MOLIMM.2020.01.009 @default.
- Q92919075 P698 31978707 @default.
- Q92919075 P1433 Q6895954 @default.
- Q92919075 P1476 "A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action" @default.
- Q92919075 P2093 "Haomin Huang" @default.
- Q92919075 P2093 "Jianhe Chen" @default.
- Q92919075 P2093 "Lan Deng" @default.
- Q92919075 P2093 "Le Zhao" @default.
- Q92919075 P2093 "Ning Yu" @default.
- Q92919075 P2093 "Qingrou Li" @default.
- Q92919075 P2093 "Wei Xu" @default.
- Q92919075 P2093 "Xuesai Zhang" @default.
- Q92919075 P2093 "Yan Yang" @default.
- Q92919075 P2093 "Zhenping Zhu" @default.
- Q92919075 P2093 "Zhibing Weng" @default.
- Q92919075 P304 "48-58" @default.
- Q92919075 P31 Q13442814 @default.
- Q92919075 P356 "10.1016/J.MOLIMM.2020.01.009" @default.
- Q92919075 P478 "119" @default.
- Q92919075 P577 "2020-01-21T00:00:00Z" @default.
- Q92919075 P698 "31978707" @default.
- Q92919075 P921 Q412616 @default.